These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 34646366)
1. LOXL2-enriched small extracellular vesicles mediate hypoxia-induced premetastatic niche and indicates poor outcome of head and neck cancer. Zhu G; Wang L; Meng W; Lu S; Cao B; Liang X; He C; Hao Y; Du X; Wang X; Li L; Li L Theranostics; 2021; 11(19):9198-9216. PubMed ID: 34646366 [TBL] [Abstract][Full Text] [Related]
2. Small extracellular vesicles containing miR-192/215 mediate hypoxia-induced cancer-associated fibroblast development in head and neck squamous cell carcinoma. Zhu G; Cao B; Liang X; Li L; Hao Y; Meng W; He C; Wang L; Li L Cancer Lett; 2021 May; 506():11-22. PubMed ID: 33639203 [TBL] [Abstract][Full Text] [Related]
3. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma. Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623 [TBL] [Abstract][Full Text] [Related]
4. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma. Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164 [TBL] [Abstract][Full Text] [Related]
5. Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma. Fukumoto I; Kikkawa N; Matsushita R; Kato M; Kurozumi A; Nishikawa R; Goto Y; Koshizuka K; Hanazawa T; Enokida H; Nakagawa M; Okamoto Y; Seki N J Hum Genet; 2016 Feb; 61(2):109-18. PubMed ID: 26490187 [TBL] [Abstract][Full Text] [Related]
6. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
7. Tumor-Derived RAB21+ABHD12+ sEVs Drive the Premetastatic Microenvironment in the Lung. Wu K; Li Y; Ji Y; Liu C; Wang X; Guo H; Zhang J; He Y Cancer Immunol Res; 2024 Feb; 12(2):161-179. PubMed ID: 38215051 [TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase like-4 monoclonal antibody demonstrates therapeutic effect against head and neck squamous cell carcinoma cells and xenografts. Görögh T; Quabius ES; Heidebrecht H; Nagy A; Muffels T; Haag J; Ambrosch P; Hoffmann M Int J Cancer; 2016 May; 138(10):2529-38. PubMed ID: 26756583 [TBL] [Abstract][Full Text] [Related]
9. Carcinoma-associated fibroblast-derived lysyl oxidase-rich extracellular vesicles mediate collagen crosslinking and promote epithelial-mesenchymal transition via p-FAK/p-paxillin/YAP signaling. Liu X; Li J; Yang X; Li X; Kong J; Qi D; Zhang F; Sun B; Liu Y; Liu T Int J Oral Sci; 2023 Aug; 15(1):32. PubMed ID: 37532712 [TBL] [Abstract][Full Text] [Related]
10. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway. Hong X; Yu JJ Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous disturbance of NHE1 and LOXL2 decreases tumorigenicity of head and neck squamous cell carcinoma. Hayashi Y; Miyoshi S; Watanabe I; Yano N; Nagashio K; Kaneko M; Kaminota T; Sanada T; Hosokawa Y; Kitani T; Mitani S; Choudhury ME; Yano H; Tanaka J; Hato N Auris Nasus Larynx; 2024 Jun; 51(3):472-480. PubMed ID: 38520980 [TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression. Martin A; Salvador F; Moreno-Bueno G; Floristán A; Ruiz-Herguido C; Cuevas EP; Morales S; Santos V; Csiszar K; Dubus P; Haigh JJ; Bigas A; Portillo F; Cano A EMBO J; 2015 Apr; 34(8):1090-109. PubMed ID: 25759215 [TBL] [Abstract][Full Text] [Related]
13. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer. Yu J; Xie F; Bao X; Chen W; Xu Q Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626 [TBL] [Abstract][Full Text] [Related]
14. Stable SET knockdown in head and neck squamous cell carcinoma promotes cell invasion and the mesenchymal-like phenotype in vitro, as well as necrosis, cisplatin sensitivity and lymph node metastasis in xenograft tumor models. Sobral LM; Sousa LO; Coletta RD; Cabral H; Greene LJ; Tajara EH; Gutkind JS; Curti C; Leopoldino AM Mol Cancer; 2014 Feb; 13():32. PubMed ID: 24555657 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma. Xu J; Lu W; Zhang S; Zhu C; Ren T; Zhu T; Zhao H; Liu Y; Su J Cancer Biol Ther; 2014 May; 15(5):612-22. PubMed ID: 24556606 [TBL] [Abstract][Full Text] [Related]
16. Notch1 regulates invasion and metastasis of head and neck squamous cell carcinoma by inducing EMT through c-Myc. Inamura N; Kimura T; Wang L; Yanagi H; Tsuda M; Tanino M; Nishihara H; Fukuda S; Tanaka S Auris Nasus Larynx; 2017 Aug; 44(4):447-457. PubMed ID: 27595504 [TBL] [Abstract][Full Text] [Related]
17. Tumor-secreted LOXL2 activates fibroblasts through FAK signaling. Barker HE; Bird D; Lang G; Erler JT Mol Cancer Res; 2013 Nov; 11(11):1425-36. PubMed ID: 24008674 [TBL] [Abstract][Full Text] [Related]
18. The pathological significance of LOXL2 in pre-metastatic niche formation of HCC and its related molecular mechanism. Wu S; Xing X; Wang Y; Zhang X; Li M; Wang M; Wang Z; Chen J; Gao D; Zhao Y; Chen R; Ren Z; Zhang K; Cui J Eur J Cancer; 2021 Apr; 147():63-73. PubMed ID: 33618200 [TBL] [Abstract][Full Text] [Related]
19. microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer. Obayashi M; Yoshida M; Tsunematsu T; Ogawa I; Sasahira T; Kuniyasu H; Imoto I; Abiko Y; Xu D; Fukunaga S; Tahara H; Kudo Y; Nagao T; Takata T Oncotarget; 2016 Feb; 7(7):8223-39. PubMed ID: 26882562 [TBL] [Abstract][Full Text] [Related]
20. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma. Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308 [No Abstract] [Full Text] [Related] [Next] [New Search]